# Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease

> **NCT05558267** · NA · NOT_YET_RECRUITING · sponsor: **NYU Langone Health** · enrollment: 20 (estimated)

## Conditions studied

- End Stage Kidney Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Standard Table Salt
- **DIETARY_SUPPLEMENT:** Salt Substitute

## Key facts

- **NCT ID:** NCT05558267
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-01-15
- **Primary completion:** 2027-06-15
- **Final completion:** 2027-06-15
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05558267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05558267, "Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05558267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*